Comparative study to evaluate dosimetric differences in patients of locally advanced carcinoma cervix undergoing intracavitary brachytherapy under two different anaesthesia techniques: an audit from a tertiary cancer centre in India

Journal of the Egyptian National Cancer Institute

Table 2 EQD2 dose received by 0.1 cc OARs

Organs at risk	Group	N	Mean	Std. deviation	Min	Max	p value	95% CI of the difference
Organs at risk	Group	N	Mean	Std. deviation	Min	Max	p value	Lower	Upper
Sigmoid colon	GA	16	75.4331	18.30633	52.28	122.12	.924	− 10.37846	11.40576
Sigmoid colon	PS	19	74.9195	13.30924	53.13	98.84	.924	− 10.37846	11.40576
Bladder	GA	16	105.1681	17.58910	63.65	127.09	.537	− 11.14112	21.00263
Bladder	PS	19	100.2374	27.12735	60.4	172.49	.537	− 11.14112	21.00263
Rectum	GA	16	72.6000	9.23701	55.14	88.30	.009*	− 19.07379	− 2.92621
Rectum	PS	19	83.6000	13.40413	60.58	118.62	.009*	− 19.07379	− 2.92621